WednesdaySep 24, 2008 11:12 am

Emotions Running High Over $700B Bailout

According to a recent poll, 55 percent of Americans do not believe that any taxpayer dollars should go to rescuing private companies, regardless of the effect that their collapse would have on the overall economy. Outrage over the plan proposed by Henry Paulson and Ben Bernanke has been steadily growing, with many citizens believing that it is just another way for the nation's rich to exploit the working class. Indeed, the government bailout would protect the fortunes of the upper one percent, but the real question is one that seems to remain largely unanswered: What sort of long-term effects would…

Continue Reading

WednesdaySep 24, 2008 11:10 am

AIG, Fannie, Freddie, and Lehman are Under Federal Investigation

Four of the nation's largest financial institutions, whose collapses have contributed significantly to the need for the pending government action plan currently being discussed in Washington, have also drawn attention from the Federal Bureau of Investigation. The FBI has stated its intent to commence fraud investigations of insurer AIG, investment bank Lehman Brothers Holdings, and mortgage financiers Fannie Mae and Freddie Mac. Limited information regarding the investigations was given, as they are in the beginning stages, but it was noted that senior officers of the financial institutions would come under the greatest scrutiny. Let us hear your thoughts below:

Continue Reading

WednesdaySep 24, 2008 11:09 am

Buffett Weighs In on Financial Crisis

In a move that many viewed as indicative of the beginning of a turn-around on Wall Street, billionaire investor Warren Buffett has placed a $5 billion bet on Goldman Sachs; one of the few banking superpowers left standing. Buffett, a trend-setter in the world of finance, commented on his own investment. "I am to some effect betting on the fact that the government will do the rational thing and act properly." In addition, Goldman stated on Wednesday that it would be raising an additional $5 billion in a public stock offering to further increase capital. Let us hear your thoughts…

Continue Reading

WednesdaySep 24, 2008 11:08 am

Dollar Sinks – Investors Turn to Gold

In the past, it has been fairly commonplace to witness gold prices rallying between the months of September and December. This year's seasonal move is expected to be magnified by a troubled U.S. dollar, which has caused a reversal in gold's downward trend. There are few, if any, who believe that the value of the dollar has anywhere to go but down. The current national debt (around $9 trillion and growing by several billion daily) is weighing heavily on U.S. currency, not to mention the proposed government bailout that could increase that number by anywhere from $250 billion to $1…

Continue Reading

WednesdaySep 24, 2008 11:05 am

NutraCea (NTRZ.OB) Caters to Chinese Baby Food Market Laden with Tainted Milk Worries

While China wrestles with tainted dairy products revolving around a “milk scandal” responsible for the deaths of four Chinese babies and the sickness of thousands more, companies such as NutraCea are addressing health and food needs in other ways. NutraCea’s product line includes nutritious ingredients for human and animal food companies, promoting health and nutrient-dense rice bran products for humanitarian feeding efforts. The company today announced it has received a purchase order to introduce nutritionally-fortified baby cereal into the Chinese market. The products are set to launch in February 2009, and soon after, the company intends for these products to…

Continue Reading

WednesdaySep 24, 2008 11:04 am

Dyax Corp. (DYAX) Announces Completion of Biologics License Application with FDA; Moves Forward with Treatment for Life-Threatening Angiodema

Dyax Corp. (Nasdaq: DYAX) focuses on the advancement of novel biotherapeutics, such as those for the treatment of hereditary angiodema (HAE), a rare and potentially life-threatening condition that occurs in about one in every 10,000 to 50,000 people. The condition is associated with swelling in various parts of the body (including hands, feet, face and airway), abdominal pain, and nausea and vomiting. Dyax today announced the completion of its Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of Dyax’s flagship product, DX-88 (ecallantide), for the treatment of HAE. “The submission of the DX-88 BLA…

Continue Reading

WednesdaySep 24, 2008 10:18 am

MyECheck, Inc. (MYEC.OB) Inks Agreement with Online Medical Supply Company

This afternoon, MyECheck announced that it has added QuickMedical as a client of its online payment processing service. MyECheck’s unique alternative payment method is the safest and most effective way to process electronic payments, and provides clients with financial access to more consumers than any other payment method. QuickMedical, a medical supply store, offers a large variety of medical equipment and medical supplies. Founded in 1993, the medical supply company currently sells more than 15,000 medical products and continues to add to its growing product line. CEO of MyECheck, Edward Starrs, stated, “Checks processed on the MyECheck processing system are…

Continue Reading

WednesdaySep 24, 2008 9:58 am

QuoteMedia, Inc. (QMCI.OB) Grows Sales & Market Share

QuoteMedia, Inc., (QMCI.OB), the $6 million financial data and software provider based in Arizona, has posted 19 consecutive quarters of revenue growth, steadily increasing its market share in the $7 billion financial data supplier market. QuoteMedia’s major competitive edge is its use of advanced technologies, offering news feeds and software solutions comparable or superior to more expensive big-name competitors such as Bloomberg or Reuters. QuoteMedia provides real-time streaming financial news and research tools to brokerage, financial service, and media corporations around the world, including NASDAQ, Dow Jones, Forbes, JP Morgan & Chase, and IBM. Its superior content delivery capabilities are…

Continue Reading

WednesdaySep 24, 2008 9:55 am

Hybrid Technologies (HYBR.OB) Offers All-Electric Sports Car

Hybrid Technologies, Inc., (HYBR.OB), the Las Vegas-based developer and marketer of all electric vehicles and conversions, now offers a knockout of a sports car. For anyone who thought electric cars have to look and perform in a way that only a diehard environmentalist would love, the LiVinizio is a revelation. It looks like a genuine sports car because it is a genuine sportscar, with specifications to back up the claim: > 0-60 in 4.0 seconds > Top speed of 160 mph > 160 miles on a single charge The LiVinizio is also the base model being used by Hybrid to…

Continue Reading

WednesdaySep 24, 2008 7:51 am

Flaherty Special Report Features Brite-Strike Tactical Illumination Products, Inc. (BSTI.PK)

This morning before the bell, Flaherty Financial News announced that an updated “Flaherty Special Report” on Brite-Strike Tactical Illumination Products, Inc. was released yesterday. The stock of the company has declined during recent stock market disturbance, making the current stock price an even bigger bargain now that the company has a total market valuation of only $3.4 million, according to the news release. Brite-Strike was co-founded by two veteran police officers who have dedicated their efforts to designing products with features officers desire. However, their cutting-edge products are not just for the professionals, but also for everyday citizens - specifically…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered